High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant? - Wikidata - awgldk - TriplyDB

High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant?

High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant?

http://www.wikidata.org/entity/Q34645259

about

Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested?Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia.Single-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen-Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic Malignancies.Murine allogeneic CD19 CAR T cells harbor potent antileukemic activity but have the potential to mediate lethal GVHD.Transplant-related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia: 25-year retrospective review Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.Risk factors in patients undergoing haploidentical hematopoietic stem cell transplantation for high-risk childhood acute leukemia.Treatment of Young Adults with Acute Lymphoblastic Leukemia.Continuing challenges and current issues in acute lymphoblastic leukemia.Survival after stem-cell transplant in pediatric and young-adult patients with relapsed and refractory B-cell acute lymphoblastic leukemia.Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia and the Role of MRD: A Single Centre Experience from India.Treosulfan-based conditioning regimens for allogeneic HSCT in children with acute lymphoblastic leukaemia.European Society for Blood and Marrow Transplantation Analysis of Treosulfan Conditioning Before Hematopoietic Stem Cell Transplantation in Children and Adolescents With Hematological Malignancies.

P2860

Q36069886-344BDF91-6D11-4D98-BE7B-B1F82FC9D1B6 Q36100435-5CB04435-449D-4BAD-84B6-45360A0EE1A8 Q36445665-B5B1742C-9EFC-4535-8395-4DFD2B731247 Q36675086-1AF0F78D-77B4-45B4-A796-439DA420F122 Q37233236-018CEAC2-470F-41AC-814C-C84A67DDAD07 Q38387292-D6098366-7364-4C60-B148-9F030FFCC60C Q38616426-1DB7534A-DB2F-4872-A029-C7A7D8BA68FA Q39206217-51C0A5FC-EE6F-499E-B380-88640145306A Q39366299-FAD1CA44-68F0-47FC-9014-49D25B920C8C Q47927762-5FE14AC1-4209-43D9-AC3B-D24A32E4A978 Q48109702-42B21BDA-901D-43C2-BFF3-D912EEA07602 Q50848271-35C360A1-2AFA-4CC9-8F69-0CF150B9A368 Q50854536-1D30081B-15C6-4121-850A-85BE1FE0CDB3

P2860

High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant?

http://www.wikidata.org/entity/Q34645259

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant?

@ast

High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant?

@en

High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant?

@nl

type

label

High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant?

@ast

High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant?

@en

High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant?

@nl

prefLabel

High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant?

@ast

High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant?

@en

High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant?

@nl

P1433

Q34645259-E3268114-B0E2-4645-84A1-29C41323A052

P1476

Q34645259-736C5981-B265-42A5-876C-E1A039A3BFEC

P2093

Q34645259-A0048A06-5414-4344-8047-4C1EE96E5C26

Q34645259-C03A9005-2F31-4DB7-9F12-28BAA34B6C07

Q34645259-D82D72C3-62A1-4A60-BE2D-6B20BCC83CE6

P2860

Q34645259-075942D3-8AD9-42E6-B757-2FEA53423495

Q34645259-0BA8D761-0D91-4F68-B0DF-472527A5D8D1

Q34645259-0BB07547-C010-4CD2-9F62-45DC8006A228

Q34645259-0F952604-7974-4961-A81C-EE89E9181A79

Q34645259-121A0E16-609B-4E3C-BFB1-63EAF97E0447

Q34645259-1B466455-09BB-4F2C-988E-245A0682F881

Q34645259-1CBA6FCE-99F2-4BD0-967E-D5FD6E72DECC

Q34645259-20A52286-D3D4-42C3-9FAE-A74A4712B3B6

Q34645259-2A686ED3-7BE0-49CF-BED4-B6E5C03295F4

Q34645259-30404B2A-DF78-405E-BD5E-F89002E142E4

P304

Q34645259-C085CDE1-0D90-4429-AF36-459861B7CB70

P31

Q34645259-C38F2351-FFBB-40CE-9BF4-30B49583072D

Q34645259-f7536855-0fba-4e1f-9bad-331b0abec9b3

P356

Q34645259-6B4DB0FD-256F-4490-AC2E-99C6F37C7C36

P433

Q34645259-64F22497-94E0-4B3A-AA2A-B392A00E7ECF

P478

Q34645259-B6ED3C8E-AE7E-4631-A743-2F68F4CE42BE

P577

Q34645259-537E52D0-98DB-4E96-9340-D8C31C1DB73F

P5875

Q34645259-D86D4C72-1B43-4C6F-A121-8020C971F9E7

P698

Q34645259-5664DC3D-44DE-47C6-8B3B-9ED773BA581B

P921

Q34645259-3D9A48B9-F443-4420-A6C2-BD87CDD584A8

P932

Q34645259-BC4C4CB9-F80E-4E61-9D46-B49651A04FCF

P356

J.BBMT.2010.10.005

P1433

Biology of Blood and Marrow Transplantation

P1476

High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant?

@en

P2093

Ching-Hon Pui

http://www.w3.org/2001/XMLSchema#string

Christina Peters

http://www.w3.org/2001/XMLSchema#string

Michael A Pulsipher

http://www.w3.org/2001/XMLSchema#string

P2860

Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program

Treating childhood acute lymphoblastic leukemia without cranial irradiation

Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Mar

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia

A phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graft versus host disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL).

Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report.

Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor.

Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood

P304

S137-48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2010.10.005

http://www.w3.org/2001/XMLSchema#string

P433

1 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49718385

http://www.w3.org/2001/XMLSchema#string

P698

21195303

http://www.w3.org/2001/XMLSchema#string

P921

P932

3053056

http://www.w3.org/2001/XMLSchema#string